{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:51Z","timestamp":1790190771068,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.autrev.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T13:31:12Z","timestamp":1364304672000},"page":"924-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens"],"prefix":"10.1016","volume":"12","author":[{"given":"Paraskevi","family":"Zisimopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talma","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.03.002_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1113\/jphysiol.1967.sp008237","article-title":"The margin of safety of neuromuscular transmission","volume":"191","author":"Paton","year":"1967","journal-title":"J Physiol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/35097557","article-title":"Induction, assembly, maturation and maintenance of a postsynaptic apparatus","volume":"2","author":"Sanes","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2013.03.002_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.03.002_bb0025","first-page":"445","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2011","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.002_bb0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.002_bb0045","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0050","doi-asserted-by":"crossref","first-page":"18052","DOI":"10.1016\/S0021-9258(19)81322-4","article-title":"Functional properties of human skeletal muscle acetylcholine receptors expressed by the TE671 cell line","volume":"263","author":"Sine","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.03.002_bb0055","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2013.03.002_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cccn.2004.05.008","article-title":"Muscle-specific receptor tyrosine kinase autoantibodies\u2014a new immunoprecipitation assay","volume":"348","author":"Matthews","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2013.03.002_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpneuro0033","article-title":"Autoimmune channelopathies","volume":"1","author":"Buckley","year":"2005","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0070","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410410404","article-title":"Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis","volume":"41","author":"MacLennan","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/0891693031000094935","article-title":"Frequency of anti-AChR epsilon subunit-specific antibodies in MG","volume":"36","author":"Ohta","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.002_bb0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/08916930903541208","article-title":"Diagnostic use of autoantibodies in myasthenia gravis","volume":"43","author":"Leite","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.002_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(96)12488-5","article-title":"Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit","volume":"207","author":"Beeson","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2013.03.002_bb0095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.410100506","article-title":"Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations","volume":"10","author":"Tindall","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2011.09.007","article-title":"Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis","volume":"240\u2013241","author":"Trakas","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0105","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2013.03.002_bb0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12264-012-1256-0","article-title":"Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis","volume":"28","author":"Shi","year":"2012","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.autrev.2013.03.002_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2010.10.023","article-title":"Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China","volume":"301","author":"Yang","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2013.03.002_bb0125","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0165-5728(84)90065-1","article-title":"A practical enzyme immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis","volume":"6","author":"Furukawa","year":"1984","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","article-title":"A sensitive non-isotopic assay for acetylcholine receptor autoantibodies","volume":"364","author":"Hewer","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2013.03.002_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/erv.10.50","article-title":"Antibody-profiling technologies for studying humoral responses to infectious agents","volume":"9","author":"Burbelo","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.autrev.2013.03.002_bb0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nmd.2010.12.003","article-title":"Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in myasthenia gravis","volume":"21","author":"Ching","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2013.03.002_bb0150","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2013.03.002_bb0155","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mus.20491","article-title":"Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis","volume":"33","author":"Farrugia","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.002_bb0160","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.002_bb0165","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.002_bb0170","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.002_bb0175","first-page":"159","article-title":"Myasthenia gravis","volume":"88","author":"Vincent","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0180","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0185","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2013.03.002_bb0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0014-5793(83)80688-7","article-title":"Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor","volume":"158","author":"Tzartos","year":"1983","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2013.03.002_bb0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1405.007","article-title":"Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains","volume":"1132","author":"Lindstrom","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.002_bb0205","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"Psaridi-Linardaki","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.03.002_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0220","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbapap.2008.04.023","article-title":"Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the Cys-loop","volume":"1784","author":"Bitzopoulou","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2013.03.002_bb0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.002_bb0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.1983.sp014943","article-title":"Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse","volume":"344","author":"Lang","year":"1983","journal-title":"J Physiol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-510X(88)90170-0","article-title":"Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect","volume":"84","author":"Mossman","year":"1988","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2013.03.002_bb0245","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0250","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.410110603","article-title":"A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel","volume":"11","author":"Engel","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0255","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"Pinching","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.03.002_bb0260","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis","volume":"297","author":"Dau","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.03.002_bb0265","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.002_bb0270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Tzartos","year":"1987","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1196\/annals.1405.017","article-title":"Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera","volume":"1132","author":"Tzartos","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.002_bb0280","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2005.01137.x","article-title":"Seronegative myasthenia gravis: disease severity and prognosis","volume":"12","author":"Romi","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0290","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","article-title":"Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis","volume":"23","author":"Guptill","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0295","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00605.x","article-title":"Immunology of disorders of neuromuscular transmission","volume":"183","author":"Vincent","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.autrev.2013.03.002_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1","volume":"195","author":"Niks","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0310","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0315","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0320","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/08916931003602130","article-title":"Clinical aspects of myasthenia explained","volume":"43","author":"Verschuuren","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.002_bb0325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0330","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0335","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0340","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2013.03.002_bb0345","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.002_bb0355","first-page":"266","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0360","first-page":"267","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2013.03.002_bb0365","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.39.10.1359","article-title":"Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis","volume":"39","author":"Tsujihata","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0370","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.164.4.1043","article-title":"Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin","volume":"164","author":"Williams","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.002_bb0375","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.37.8.1329","article-title":"Antifilamin, antivinculin, and antitropomyosin antibodies in myasthenia gravis","volume":"37","author":"Yamamoto","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0380","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-8981(90)90110-E","article-title":"Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: identification of anti-myosin, actomyosin, actin, and alpha-actinin antibodies by a solid-phase radioimmunoassay and a western blotting analysis","volume":"187","author":"Ohta","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2013.03.002_bb0385","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0165-5728(81)90021-7","article-title":"Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination","volume":"1","author":"Aarli","year":"1981","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.56.1.25","article-title":"Late-onset myasthenia gravis: a changing scene","volume":"56","author":"Aarli","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0395","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/mus.20886","article-title":"Structure\u2013function relations of the giant elastic protein titin in striated and smooth muscle cells","volume":"36","author":"Granzier","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.002_bb0400","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.43.8.1581","article-title":"Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin","volume":"43","author":"Gautel","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0405","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410320419","article-title":"Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma","volume":"32","author":"Mygland","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/08916939409010673","article-title":"Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis","volume":"17","author":"Mygland","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.002_bb0415","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0404.2005.00374.x","article-title":"Myasthenia gravis: clinical, immunological, and therapeutic advances","volume":"111","author":"Romi","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2013.03.002_bb0420","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2013.03.002_bb0425","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.002_bb0430","first-page":"474512","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.002_bb0435","series-title":"12th International Conference on Myasthenia Gravis and Related Disorders, May 21\u201323","article-title":"A multinational study on the detection of autoantibodies to the novel antigen LRP4, in double seronegative myasthenia gravis patient sera","author":"Zisimopoulou","year":"2012"},{"key":"10.1016\/j.autrev.2013.03.002_bb0440","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.002_bb0445","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.autrev.2013.03.002_bb0450","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2013.03.002_bb0455","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2013.03.002_bb0460","series-title":"12th International Conference on Myasthenia Gravis and Related Disorders, May 21\u201323","article-title":"The search for new antigenic targets in myasthenia gravis","author":"Belaya","year":"2012"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T14:49:08Z","timestamp":1688136548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1568997213000281"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}